StockData

Aquestive Therapeutics vs Aytu BioPharma

AQST and AYTU side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How AQST and AYTU compare

Aquestive Therapeutics is the larger company, worth 16 times as much as Aytu BioPharma ($464M against $28.9M).

Aquestive Therapeutics grew revenue faster over the last twelve months (22.6% versus −13.3% for Aytu BioPharma).

Aytu BioPharma keeps more of each dollar of sales as profit, with a net margin of −24.8% compared with −145% at Aquestive Therapeutics.

Aytu BioPharma scores higher on the StockData Score (9 against 3 for Aquestive Therapeutics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricAQSTAYTU
Size and price
Market cap$464M$28.9M
Share price$3.70$2.66
Change, 1 year−31.4%27.3%
Change, 5 years−41.9%−93.2%
Beta (5Y)1.20−0.05
Employees14776
StockData Score
Total score39 (better)
Valuation score03 (better)
Growth score2 (better)0
Performance score03 (better)
Health score13 (better)
Dividend score00
Valuation
P/S8.6×0.5× (better)
P/B–0.8×
P/FCF–8.9×
FCF yield−9.9%11.3% (better)
Fair value–$8.97
Margin of safety–70.4%
Growth
Revenue growth (TTM)22.6% (better)−13.3%
Revenue growth, 5Y average−0.58% (better)−2.6%
Profitability
Gross margin67.0% (better)64.0%
Operating margin−97.5%−14.4% (better)
Net margin−145%−24.8% (better)
FCF margin−85.0%5.6% (better)
Return on equity–−52.6%
Return on invested capital–−63.5%
Financial health
Debt / equity–0.31
Interest coverage−4.7×−4.4× (better)
Current ratio7.19 (better)1.13
Altman Z-score−3.57 (better)−4.02
Piotroski F-score23 (better)
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions57.4%45.3%
Held by insiders3.2%15.1%
Insider net buying, 12 months−$2.3M–
Short interest, % of float24.1%3.3%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.